City of Hope

City of Hope, a NCI-designated Comprehensive Cancer Center

Page Title

Skip Navigation

Global Navigation



Border Border
  
  PROFILE 
The following is a list of available studies directed by  Vinod Pullarkat, MD  
Search results:  3  Clinical trial(s) found  (Page 1 of 1 )
 
Click here to generate a printer-friendly view  
 09187
   P.I.: Vinod Pullarkat, MD (Institutional)
Title: Deferasirox Treatment and Labile Plasma Iron in Iron Overloaded Patients who have Undergone Allogeneic Hematopoietic Stem Cell Transplantation
 
Click here for  Full Eligibility Criteria
 09050
   P.I.: Vinod Pullarkat, MD (Institutional)
Title: Immune Responses in Acute Leukemia and Chronic Myeloid Leukemia
 03162
   P.I.: Vinod Pullarkat, MD (Institutional)
Title: Molecular Pathogenesis of Acute Leukemia and Myelodysplasia
 

  
NCI CCC LogoCity of Hope, An NCI-designated Comprehensive Cancer Center, is an innovative biomedical research, treatment and educational institution dedicated to the prevention and cure of cancer and other life-threatening illness.
Best Of logoCity of Hope has been named one of "America's Best Hospitals" in cancer and urology by U.S. News & World Report. Read more here...
NCI CCC LogoThe National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HONcode of the Healthcare on the Net Foundation.